Contineum Therapeutics (CTNM) Other Gross PP&E Adjustments (2023 - 2026)
Contineum Therapeutics' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$7.0 million for Q1 2026.
- Quarterly Other Gross PP&E Adjustments fell 31.12% to -$7.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.0 million through Mar 2026, down 31.12% year-over-year, with the annual reading at -$7.0 million for FY2025, 81.01% down from the prior year.
- Other Gross PP&E Adjustments came in at -$7.0 million for Q1 2026, roughly flat from -$7.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $602000.0 in Q4 2023 to a low of -$7.0 million in Q4 2025.
- The 4-year median for Other Gross PP&E Adjustments is -$4.4 million (2024), against an average of -$3.6 million.
- Year-over-year, Other Gross PP&E Adjustments crashed 2354.82% in 2025 and then plummeted 31.12% in 2026.
- Contineum Therapeutics' Other Gross PP&E Adjustments stood at $602000.0 in 2023, then plummeted by 744.85% to -$3.9 million in 2024, then crashed by 81.01% to -$7.0 million in 2025, then rose by 0.16% to -$7.0 million in 2026.
- Per Business Quant, the three most recent readings for CTNM's Other Gross PP&E Adjustments are -$7.0 million (Q1 2026), -$7.0 million (Q4 2025), and -$4.8 million (Q3 2025).